Myriad Genetics (MYGN) announced the appointment of Brian Donnelly as CCO, effective May 1, 2025. Prior to joining Myriad Genetics, Donnelly held senior commercial and general management roles at ...

announced today the appointment of Brian Donnelly as chief commercial officer (CCO), effective May 1, 2025. A strategic, results-oriented leader with more than 20 years of experience in healthcare ...